Moneycontrol
HomeNewscoronavirusDelta Plus, Kappa, Lambda, Epsilon: What are these coronavirus variants, can vaccines fight them, and other queries answered

Delta Plus, Kappa, Lambda, Epsilon: What are these coronavirus variants, can vaccines fight them, and other queries answered

At present, the Delta variant is fast emerging to be the most dominant SARS-CoV-2 strain in the world. Some of the other variants of the novel coronavirus that have left health experts concerned are the Delta Plus and Lambda variants.

July 12, 2021 / 17:38 IST
Story continues below Advertisement
Representative image

All viruses, including SARS-CoV-2 -- which causes COVID-19 – evolve over time. When a virus replicates, some of its attributes change at times; these changes are called “mutations”. A virus with one or more new mutations is referred to as a “variant” of the original virus.

At present, the Delta variant is fast emerging to be the most dominant strain in the world. Some of the other variants of the novel coronavirus that have left health experts concerned are the Delta Plus and Lambda variants.

Story continues below Advertisement

Some of the dominant COVID-19 variants:

Delta variant: The Delta variant of the novel coronavirus or the B.1.617.2 strain, which was first detected in India, is now the dominant strain of COVID-19 in multiple countries. It has now become dominant in India, Singapore, the United Kingdom, and the United States and has been detected in more than 70 countries so far. The WHO elevated the Delta variant from ‘Variant of Interest’ to a ‘Variant of Concern’ citing “significantly increased transmissibility” and a “growing number of countries reporting outbreaks associated with this variant”.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show